购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-52 (Compound 84) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,展现出对雌二醇的极低IC50值,即 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病及心血管疾病,特别是非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)以及药物性肝损伤(DILI)等症。
HSD17B13-IN-52 (Compound 84) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,展现出对雌二醇的极低IC50值,即 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病及心血管疾病,特别是非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)以及药物性肝损伤(DILI)等症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-52 (Compound 84), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibits potent activity with an IC50 value of ≤ 0.1 μM against estradiol. This compound is applicable in the research of various health conditions including liver, metabolic, and cardiovascular diseases, specifically NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
分子量 | 525.38 |
分子式 | C26H22Cl2N4O4 |
CAS No. | 2770246-77-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容